pillbase.ru

Orencia

Active substance: abatacept

abatacept

Centralised EU authorisationActive

Marketing holder: Bristol-Myers Squibb Pharma EEIG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • ORENCIA
    INJECTION, SOLUTION · ABATACEPT 87.5 mg/.7mL
    0003-2818
    E.R. Squibb & Sons, L.L.C.
  • ORENCIA
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ABATACEPT 250 mg/15mL
    0003-2187
    E.R. Squibb & Sons, L.L.C.
  • ORENCIA
    INJECTION, SOLUTION · ABATACEPT 50 mg/.4mL
    0003-2814
    E.R. Squibb & Sons, L.L.C.
  • ORENCIA
    INJECTION, SOLUTION · ABATACEPT 125 mg/mL
    0003-2188
    E.R. Squibb & Sons, L.L.C.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4cc3-7d43-a172-7c3b96941ce7,01a1208d-0022-724c-9d6a-1c030e857292,01a1208e-0e56-7d2e-830f-9dd520339eee,01a12091-7174-7458-a6d5-a3e71239238b;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000701
Registration status
Active
ATC code
L04AA24
Sources
  • product · EMA · EMEA/H/C/000701 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000701 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000701 · Verified 2026-10-09